Posted on

DermTech Expands Telehealth Application, DermTech Connect, Across 44 States

DermTech, Inc. (NASDAQ: DMTK) (‘DermTech’ or the ‘Company’), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today the expansion of access to its telehealth application, DermTech Connect, from eight states to 44 states, encompassing approximately 95% of the U.S. population. The mobile app provides improved access to an independent dermatologist, allowing users to choose when to have a mole evaluated by a dermatologist without a trip to a doctor’s office.